Third, we were unable to determine the oral intake of Zn and serum albumin level which could affected to the lower Zn in NAFLD because the data from the KNHANES did not provide information about Zn intake and albumin. The gene discussed is ALB; the disease is metabolic dysfunction-associated steatotic liver disease.